Risk of AKI with gentamicin as surgical prophylaxis

Samira Bell, Peter Davey, Dilip Nathwani, Charis Marwick, Thenmalar Vadiveloo, Jacqueline Sneddon, Andrea Patton, Marion Bennie, Stewart Fleming, Peter T. Donnan

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

In 2009, the Scottish government issued a target to reduce Clostridium difficile infection by 30% in 2 years. Consequently, Scottish hospitals changed from cephalosporins to gentamicin for surgical antibiotic prophylaxis. This study examined rates of postoperative AKI before and after this policy change. The study population comprised 12,482 adults undergoing surgery (orthopedic, urology, vascular, gastrointestinal, and gynecology) with antibiotic prophylaxis between October 1, 2006, and September 30, 2010 in the Tayside region of Scotland. Postoperative AKI was defined by the Kidney Disease Improving Global Outcomes criteria. The study design was an interrupted time series with segmented regression analysis. In orthopedic patients, change in policy from cefuroxime to flucloxacillin (two doses of 1 g) and single-dose gentamicin (4 mg/kg) was associated with a 94% increase in AKI (P=0.04; 95% confidence interval, 93.8% to 94.3%). Most patients who developed AKI after prophylactic gentamicin had stage 1 AKI, but some patients developed persistent stage 2 or stage 3 AKI. The antibiotic policy change was not associated with a significant increase in AKI in the other groups. Regardless of antibiotic regimen, however, rates of AKI were high (24%) after vascular surgery, and increased steadily after gastrointestinal surgery. Rates could only be ascertained in 52% of urology patients and 47% of gynecology patients because of a lack of creatinine testing. These results suggest that gentamicin should be avoided in orthopedic patients in the perioperative period. Our findings also raise concerns about the increasing prevalence of postoperative AKI and failures to consistently measure postoperative renal function.

LanguageEnglish
Pages2625-2632
Number of pages8
JournalJournal of the American Society of Nephrology
Volume25
Issue number11
Early online date29 May 2014
DOIs
Publication statusPublished - 1 Nov 2014

Fingerprint

Gentamicins
Orthopedics
Antibiotic Prophylaxis
Urology
Gynecology
Blood Vessels
Floxacillin
Anti-Bacterial Agents
Clostridium Infections
Cefuroxime
Perioperative Period
Clostridium difficile
Kidney Diseases
Scotland
Cephalosporins
Creatinine
Regression Analysis
Confidence Intervals
Kidney
Population

Keywords

  • clostridium difficile
  • Scottish hospitals
  • antibiotic prophylaxis
  • postoperative AKI

Cite this

Bell, S., Davey, P., Nathwani, D., Marwick, C., Vadiveloo, T., Sneddon, J., ... Donnan, P. T. (2014). Risk of AKI with gentamicin as surgical prophylaxis. Journal of the American Society of Nephrology, 25(11), 2625-2632. https://doi.org/10.1681/ASN.2014010035
Bell, Samira ; Davey, Peter ; Nathwani, Dilip ; Marwick, Charis ; Vadiveloo, Thenmalar ; Sneddon, Jacqueline ; Patton, Andrea ; Bennie, Marion ; Fleming, Stewart ; Donnan, Peter T. / Risk of AKI with gentamicin as surgical prophylaxis. In: Journal of the American Society of Nephrology. 2014 ; Vol. 25, No. 11. pp. 2625-2632.
@article{6bdc96caa85f4e6a935eb2f2a61ccd89,
title = "Risk of AKI with gentamicin as surgical prophylaxis",
abstract = "In 2009, the Scottish government issued a target to reduce Clostridium difficile infection by 30{\%} in 2 years. Consequently, Scottish hospitals changed from cephalosporins to gentamicin for surgical antibiotic prophylaxis. This study examined rates of postoperative AKI before and after this policy change. The study population comprised 12,482 adults undergoing surgery (orthopedic, urology, vascular, gastrointestinal, and gynecology) with antibiotic prophylaxis between October 1, 2006, and September 30, 2010 in the Tayside region of Scotland. Postoperative AKI was defined by the Kidney Disease Improving Global Outcomes criteria. The study design was an interrupted time series with segmented regression analysis. In orthopedic patients, change in policy from cefuroxime to flucloxacillin (two doses of 1 g) and single-dose gentamicin (4 mg/kg) was associated with a 94{\%} increase in AKI (P=0.04; 95{\%} confidence interval, 93.8{\%} to 94.3{\%}). Most patients who developed AKI after prophylactic gentamicin had stage 1 AKI, but some patients developed persistent stage 2 or stage 3 AKI. The antibiotic policy change was not associated with a significant increase in AKI in the other groups. Regardless of antibiotic regimen, however, rates of AKI were high (24{\%}) after vascular surgery, and increased steadily after gastrointestinal surgery. Rates could only be ascertained in 52{\%} of urology patients and 47{\%} of gynecology patients because of a lack of creatinine testing. These results suggest that gentamicin should be avoided in orthopedic patients in the perioperative period. Our findings also raise concerns about the increasing prevalence of postoperative AKI and failures to consistently measure postoperative renal function.",
keywords = "clostridium difficile, Scottish hospitals, antibiotic prophylaxis, postoperative AKI",
author = "Samira Bell and Peter Davey and Dilip Nathwani and Charis Marwick and Thenmalar Vadiveloo and Jacqueline Sneddon and Andrea Patton and Marion Bennie and Stewart Fleming and Donnan, {Peter T.}",
year = "2014",
month = "11",
day = "1",
doi = "10.1681/ASN.2014010035",
language = "English",
volume = "25",
pages = "2625--2632",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
number = "11",

}

Bell, S, Davey, P, Nathwani, D, Marwick, C, Vadiveloo, T, Sneddon, J, Patton, A, Bennie, M, Fleming, S & Donnan, PT 2014, 'Risk of AKI with gentamicin as surgical prophylaxis' Journal of the American Society of Nephrology, vol. 25, no. 11, pp. 2625-2632. https://doi.org/10.1681/ASN.2014010035

Risk of AKI with gentamicin as surgical prophylaxis. / Bell, Samira; Davey, Peter; Nathwani, Dilip; Marwick, Charis; Vadiveloo, Thenmalar; Sneddon, Jacqueline; Patton, Andrea; Bennie, Marion; Fleming, Stewart; Donnan, Peter T.

In: Journal of the American Society of Nephrology, Vol. 25, No. 11, 01.11.2014, p. 2625-2632.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Risk of AKI with gentamicin as surgical prophylaxis

AU - Bell, Samira

AU - Davey, Peter

AU - Nathwani, Dilip

AU - Marwick, Charis

AU - Vadiveloo, Thenmalar

AU - Sneddon, Jacqueline

AU - Patton, Andrea

AU - Bennie, Marion

AU - Fleming, Stewart

AU - Donnan, Peter T.

PY - 2014/11/1

Y1 - 2014/11/1

N2 - In 2009, the Scottish government issued a target to reduce Clostridium difficile infection by 30% in 2 years. Consequently, Scottish hospitals changed from cephalosporins to gentamicin for surgical antibiotic prophylaxis. This study examined rates of postoperative AKI before and after this policy change. The study population comprised 12,482 adults undergoing surgery (orthopedic, urology, vascular, gastrointestinal, and gynecology) with antibiotic prophylaxis between October 1, 2006, and September 30, 2010 in the Tayside region of Scotland. Postoperative AKI was defined by the Kidney Disease Improving Global Outcomes criteria. The study design was an interrupted time series with segmented regression analysis. In orthopedic patients, change in policy from cefuroxime to flucloxacillin (two doses of 1 g) and single-dose gentamicin (4 mg/kg) was associated with a 94% increase in AKI (P=0.04; 95% confidence interval, 93.8% to 94.3%). Most patients who developed AKI after prophylactic gentamicin had stage 1 AKI, but some patients developed persistent stage 2 or stage 3 AKI. The antibiotic policy change was not associated with a significant increase in AKI in the other groups. Regardless of antibiotic regimen, however, rates of AKI were high (24%) after vascular surgery, and increased steadily after gastrointestinal surgery. Rates could only be ascertained in 52% of urology patients and 47% of gynecology patients because of a lack of creatinine testing. These results suggest that gentamicin should be avoided in orthopedic patients in the perioperative period. Our findings also raise concerns about the increasing prevalence of postoperative AKI and failures to consistently measure postoperative renal function.

AB - In 2009, the Scottish government issued a target to reduce Clostridium difficile infection by 30% in 2 years. Consequently, Scottish hospitals changed from cephalosporins to gentamicin for surgical antibiotic prophylaxis. This study examined rates of postoperative AKI before and after this policy change. The study population comprised 12,482 adults undergoing surgery (orthopedic, urology, vascular, gastrointestinal, and gynecology) with antibiotic prophylaxis between October 1, 2006, and September 30, 2010 in the Tayside region of Scotland. Postoperative AKI was defined by the Kidney Disease Improving Global Outcomes criteria. The study design was an interrupted time series with segmented regression analysis. In orthopedic patients, change in policy from cefuroxime to flucloxacillin (two doses of 1 g) and single-dose gentamicin (4 mg/kg) was associated with a 94% increase in AKI (P=0.04; 95% confidence interval, 93.8% to 94.3%). Most patients who developed AKI after prophylactic gentamicin had stage 1 AKI, but some patients developed persistent stage 2 or stage 3 AKI. The antibiotic policy change was not associated with a significant increase in AKI in the other groups. Regardless of antibiotic regimen, however, rates of AKI were high (24%) after vascular surgery, and increased steadily after gastrointestinal surgery. Rates could only be ascertained in 52% of urology patients and 47% of gynecology patients because of a lack of creatinine testing. These results suggest that gentamicin should be avoided in orthopedic patients in the perioperative period. Our findings also raise concerns about the increasing prevalence of postoperative AKI and failures to consistently measure postoperative renal function.

KW - clostridium difficile

KW - Scottish hospitals

KW - antibiotic prophylaxis

KW - postoperative AKI

UR - http://jasn.asnjournals.org/content/25/11/2625

U2 - 10.1681/ASN.2014010035

DO - 10.1681/ASN.2014010035

M3 - Article

VL - 25

SP - 2625

EP - 2632

JO - Journal of the American Society of Nephrology

T2 - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - 11

ER -

Bell S, Davey P, Nathwani D, Marwick C, Vadiveloo T, Sneddon J et al. Risk of AKI with gentamicin as surgical prophylaxis. Journal of the American Society of Nephrology. 2014 Nov 1;25(11):2625-2632. https://doi.org/10.1681/ASN.2014010035